Development and characterization of Emulgel a Novel formulation for topical drug delivery of Ofloxacin

Authors

  • Deepika Varvade
  • Ashwani Mishra

DOI:

https://doi.org/10.37591/(rrjops).v10i2.545

Abstract

The aim of this work is to develop best Emulgel formulation carrying Antifungal agent Ofloxacin Emulgel has been emerged as a promising drug delivery system. Formulation of Ofloxacin Emulgel was done by using Carbopol 934 as a gelling agent, liquid paraffin as hydrophobic phase, Tween-80 and span-80 as emulsifiers and surfactant. Ofloxacin has been used in pharmaceutical formulation since it has antimicrobial activity. It acts by inhibiting bacterial DNA gyrase and topoisomerase that prevent the supercoiling of DNA during replication and transcription by inhibits their function. It inhibits normal cell division. Final formulation was formulated in two steps, first emulsion was prepared and then it was incorporated in the gel base. The prepared formulations were evaluated for rheological studies, spreading coefficient studies, bio-adhesive strength, skin irritation studies, in vitro release, average globule size, in vivo release studies. It was concluded that Ofloxacin Emulgel formulation batch F4 prepared by using Carbopol 934 as gelling agent was the best prepared formulation among all the prepared batches. It can also be concluded that Emulgel is a wonderful drug delivery system to deliver the drug.

 

Keywords: Emulgel, Ofloxacin, Topical drug delivery

Cite this Article

Varvade Deepika, Mishra Ashwani. Development and Characterization of Emulgel a Novel Formulation for Topical Drug Delivery of Ofloxacin. Research & Reviews: A Journal of Pharmaceutical Science. 2019; 10(2): 19–23p.

Downloads

Published

2019-08-26

Issue

Vol. 10 No. 2 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.